Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Promising phase I/II findings in NSCLC reported for INGN-201 at ASCO

May 20, 1998

Pharmacokinetics of capecitabine affected by food

May 20, 1998

C225 + radiotherapy produces 100% response rate in head and neck cancer

May 19, 1998

Cytokine suppressants: an effective approach to the treatment of cancer cachexia

May 19, 1998

Phase I toxicity and efficacy results for CT-2584 presented at ASCO meeting

May 19, 1998

Matrix proceeds with full enrollment for IntraDose phase II trials

May 19, 1998

Batimastat enhances antitumor activity of cisplatin against ovarian cancer

May 19, 1998

Mechanism of antitumor activity of clotrimazole identified

May 18, 1998

U.S. patent issues for ImClone Systems' flk-1/KDR receptor-targeting antibodies

May 18, 1998

SU-5416 advances to phase I/II trials in Kaposi's sarcoma

May 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...